LeukoSite

LeukoSite develops antibody treatment and care.

Business Model:

Revenue: $0

Employees: 51-200

Rankings

Detailed LeukoSite Information

LeukoSite was acquired by Millennium Pharmaceuticals.
The acquisition happend on 1999-10-17.
Details of the transaction were not public

Geographic Data

LeukoSite headquarters map

Address:

City: Cambridge

State: Massachusetts

Zip:

Country: United States

Financial Info

Stage:

post ipo equity

Raised Last:

$12M

Raised Total:

$12M

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

LeukoSite provides treatment and cares for inflammatory, autoimmune, cancer applications, and viral diseases.

Contact Phone:

Contact Email:

LeukoSite went public on 6/27/1997 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
6/27/1997

Ticker Symbol:
LKST

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
7/1998 Post-IPO Equity $12M
1/1997 Post-IPO Equity 1 - SV Health Investors
SV Health Investors
1/1997 Post-IPO Equity 1 - SV Health Investors
SV Health Investors
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research